SGI-1776 T3078
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SGI-1776 has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias.
CAS nr:
1025065-69-3
Purity:
98%
Molecular Weight:
405,42
SMILES:
CN1CCC(CNc2nn3c(cc2)ncc3c2cc(OC(F)(F)F)ccc2)CC1
Formula:
C20H22F3N5O
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Autophagy,Apoptosis,JAK/STAT signaling,Chromatin/Epigenetic
Target:
FLT,FLT,Autophagy,Apoptosis,Pim,Pim
